These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24821087)

  • 1. A patent review of glucokinase activators and disruptors of the glucokinase--glucokinase regulatory protein interaction: 2011-2014.
    Filipski KJ; Pfefferkorn JA
    Expert Opin Ther Pat; 2014 Aug; 24(8):875-91. PubMed ID: 24821087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel glucokinase activators: a patent review (2008 - 2010).
    Sarabu R; Berthel SJ; Kester RF; Tilley JW
    Expert Opin Ther Pat; 2011 Jan; 21(1):13-33. PubMed ID: 21155690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targeting of the GK-GKRP pathway in diabetes.
    Hale C; Lloyd DJ; Pellacani A; Véniant MM
    Expert Opin Ther Targets; 2015 Jan; 19(1):129-39. PubMed ID: 25324018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting glucokinase activation for the treatment of type 2 diabetes--a status review.
    Sarabu R; Grimsby J
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):631-7. PubMed ID: 16159025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of glucokinase by glucose, small-molecule activator and glucokinase regulatory protein: steady-state kinetic and cell-based analysis.
    Bourbonais FJ; Chen J; Huang C; Zhang Y; Pfefferkorn JA; Landro JA
    Biochem J; 2012 Feb; 441(3):881-7. PubMed ID: 22044397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule disruptors of the glucokinase-glucokinase regulatory protein interaction: 1. Discovery of a novel tool compound for in vivo proof-of-concept.
    Ashton KS; Andrews KL; Bryan MC; Chen J; Chen K; Chen M; Chmait S; Croghan M; Cupples R; Fotsch C; Helmering J; Jordan SR; Kurzeja RJ; Michelsen K; Pennington LD; Poon SF; Sivits G; Van G; Vonderfecht SL; Wahl RC; Zhang J; Lloyd DJ; Hale C; St Jean DJ
    J Med Chem; 2014 Jan; 57(2):309-24. PubMed ID: 24405172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Updates on Glucokinase Activators and Glucokinase Regulatory Protein Disrupters for the Treatment of Type 2 Diabetes Mellitus.
    Kaushik A; Kaushik M
    Curr Diabetes Rev; 2019; 15(3):205-212. PubMed ID: 30039763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for the design of hepatoselective glucokinase activators to treat type 2 diabetes.
    Pfefferkorn JA
    Expert Opin Drug Discov; 2013 Mar; 8(3):319-30. PubMed ID: 23289965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational Analysis.
    Tamayo NA; Norman MH; Bartberger MD; Hong FT; Bo Y; Liu L; Nishimura N; Yang KC; Tadesse S; Fotsch C; Chen J; Chmait S; Cupples R; Hale C; Jordan SR; Lloyd DJ; Sivits G; Van G; St Jean DJ
    J Med Chem; 2015 Jun; 58(11):4462-82. PubMed ID: 25914941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucokinase activators.
    Filipski KJ; Futatsugi K; Pfefferkorn JA; Stevens BD
    Pharm Pat Anal; 2012 Jul; 1(3):301-11. PubMed ID: 24236843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Small-Molecule Glucokinase Regulatory Protein Modulators That Restore Glucokinase Activity.
    Chen K; Michelsen K; Kurzeja RJ; Han J; Vazir M; St Jean DJ; Hale C; Wahl RC
    J Biomol Screen; 2014 Aug; 19(7):1014-23. PubMed ID: 24717911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.
    Xu J; Lin S; Myers RW; Addona G; Berger JP; Campbell B; Chen HS; Chen Z; Eiermann GJ; Elowe NH; Farrer BT; Feng W; Fu Q; Kats-Kagan R; Kavana M; Malkani S; McMasters DR; Mitra K; Pachanski MJ; Tong X; Trujillo ME; Xu L; Zhang B; Zhang F; Zhang R; Parmee ER
    Bioorg Med Chem Lett; 2017 May; 27(9):2069-2073. PubMed ID: 28284804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus.
    Grewal AS; Sekhon BS; Lather V
    Mini Rev Med Chem; 2014; 14(7):585-602. PubMed ID: 25052034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glucokinase and glucokinase regulatory proteins as molecular targets for novel antidiabetic drugs].
    Rubtsov PM; Igudin EL; Tiulpakov AN
    Mol Biol (Mosk); 2015; 49(4):555-60. PubMed ID: 26299854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent clinical advances of glucokinase activators in the treatment of diabetes mellitus type 2.
    Li W; Zhang X; Sun Y; Liu Z
    Pharmazie; 2020 Jun; 75(6):230-235. PubMed ID: 32539915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.
    Matschinsky FM; Zelent B; Doliba NM; Kaestner KH; Vanderkooi JM; Grimsby J; Berthel SJ; Sarabu R
    Handb Exp Pharmacol; 2011; (203):357-401. PubMed ID: 21484579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in glucokinase activators for the treatment of type 2 diabetes.
    Pal M
    Drug Discov Today; 2009 Aug; 14(15-16):784-92. PubMed ID: 19520181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic effects of glucokinase regulatory protein small-molecule disruptors.
    Lloyd DJ; St Jean DJ; Kurzeja RJ; Wahl RC; Michelsen K; Cupples R; Chen M; Wu J; Sivits G; Helmering J; Komorowski R; Ashton KS; Pennington LD; Fotsch C; Vazir M; Chen K; Chmait S; Zhang J; Liu L; Norman MH; Andrews KL; Bartberger MD; Van G; Galbreath EJ; Vonderfecht SL; Wang M; Jordan SR; Véniant MM; Hale C
    Nature; 2013 Dec; 504(7480):437-40. PubMed ID: 24226772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucokinase activators: Novo Nordisk's WO2008084044 and Array Biopharma's WO2008091770.
    Tilley JW
    Expert Opin Ther Pat; 2009 Apr; 19(4):549-53. PubMed ID: 19441933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GKAs for diabetes therapy: why no clinically useful drug after two decades of trying?
    Matschinsky FM
    Trends Pharmacol Sci; 2013 Feb; 34(2):90-9. PubMed ID: 23305809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.